Drugs Controller General of India
08 May 2021
DRDO's anti-coronavirus drug cleared for emergency use by DCGI
The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-coronavirus drug developed by a laboratory of the Defence Research and Development Organisation (DRDO) to treat moderate to severe patients, reports say.
20 Jan 2021
Panel recommends permission for Phase I Intranasal COVID-19 vaccine trial
An expert panel, Central Drugs Standard Control Organisation, (CDSCO) on Tuesday recommended granting permission for conducting the Phase I clinical trial of an intranasal vaccine against COVID-19 developed by Bharat Biotech, official sources said.
05 Jan 2021
Sleeves up! Coronavirus vaccination drive could begin on January 13
The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.
05 Jan 2021
SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
03 Jan 2021
All you need to know about vaccines approved in India
Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.
03 Jan 2021
SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.
03 Jan 2021
Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.
02 Jan 2021
All states to hold dry run for coronavirus vaccination today
A dry run for vaccination, before the actual doses of the coronavirus vaccine are administered to people, will be held in all states and union territories today.
01 Jan 2021
India set to start COVID-19 vaccination; panel approves Oxford vaccine
In a development that will soothe the coronavirus-battered nation, the Central Drugs Standard Control Organization (CDSCO) panel on Friday gave approval to the vaccine developed by the University of Oxford and British-pharma giant AstraZeneca.
31 Dec 2020
India could start 2021 with COVID-19 vaccine in hand: DCGI
The approval for a COVID-19 vaccine in India is likely just around the corner, with the Drugs Controller General of India, Dr. VG Somani, indicating the country might begin the New Year with a vaccine in hand.
08 Dec 2020
Now, Bharat Biotech seeks emergency use approval for COVAXIN
After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN.
06 Dec 2020
Pfizer seeks emergency approval for COVID-19 vaccine in India
United States-based pharmaceutical giant Pfizer has sought emergency approval for its COVID-19 vaccine from India's drug regulator.
31 Oct 2020
AIIMS to submit proposal for COVAXIN's phase three trials soon
By early next week, AIIMS will submit a proposal to start the third phase of clinical trials of COVAXIN, a vaccine against coronavirus being developed by Bharat Biotech.
29 Oct 2020
Oxford's coronavirus vaccine could be available by December: Adar Poonawalla
In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.
23 Sep 2020
Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here
In a major move, Bharat Biotech has signed an agreement to license a nasal COVID-19 vaccine developed by the Washington University School of Medicine in St. Louis, United States.
23 Sep 2020
NewsBytes Briefing: China won't approve TikTok deal, and more
Even as TikTok, Oracle, and Walmart came close to finalizing a deal, China is not ready to let the service off the hook.
21 Sep 2020
Coronavirus: What is the 'Feluda' test? How does it work?
The Drugs Controller General of India (DCGI) has approved for commercial launch of a CRISPR-based test for COVID-19, called 'Feluda'.
03 Aug 2020
SII gets nod for Oxford COVID vaccine phase 2/3 trials
The Serum Institute of India (SII) has gotten the approval to conduct phase 2 and 3 human clinical trials of the COVID-19 vaccine candidate developed by Oxford University.
07 Jul 2020
Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable
On July 2, the Indian Council of Medical Research (ICMR) revealed its plans to launch COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech and ICMR, by August 15.
03 Jul 2020
India's second COVID-19 vaccine cleared for human trials: Details here
India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.
20 Jun 2020
Glenmark launches COVID-19 drug FabiFlu at Rs. 103 per tablet
Glenmark Pharmaceuticals Ltd. launched the antiviral drug favipiravir on Saturday for the treatment of mild to moderate cases of COVID-19.
02 Jun 2020
Remdesivir reportedly approved for COVID-19 treatment in India
Remdesivir has been approved by India's top drug regulator for "restricted emergency use" on COVID-19-infected adults and children.
26 Sep 2019
GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance
Amid an ongoing probe into Ranitidine's reported cancer-causing impurities, GlaxoSmithKline Pharmaceuticals Limited (GSK) has recalled Ranitidine-based antacid Zinetac (150mg and 300mg) in India and other markets.
29 Jun 2017
'Vegetarian' capsules: Government forwards controversial proposal to scientific panel
For the benefit of vegetarians, the government is considering substituting animal-based gelatin coating on capsules with plant cellulose.
28 Apr 2017
Deep nexus: Swiss firm Roche allegedly blocked cheaper cancer drugs
Competition Commission of India, the country's anti-trust regulator, has ordered a probe against Swiss drug maker Roche, which was allegedly attempting to maintain monopoly in the breast cancer drug market.